| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.025 | 0.8 |